5Lepper P M;Grusa E;Roichl H.Consumption of Imipenem correlates with β-lactam resistance in Pseudomonas aeruginosa[J],2002(09).
6Okamoto K;Gotoh N;Nishino T.Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics:penem resistance mechanisms and their interplay[J],2001(07).
7Ho S E;Subramaniam G;Palasubramaniam S.Carbapenem-resistant Pseudomonas aeruginosa in Malaysia producing IMP-7 beta-lactamase[J],2002(10).
8Cardoso O;Leitao R;Figueiredo A.Metallo-beta-lactamase VIM-2 in clinical isolates of Pseudomonas aeruginosa from Portugal,2002(02).
9Cunha B A.Pseudomonas aeruginosa: Resistance and therapy[J],2002(03).
10Cunha B A.Strategies to control antibiotic resistance[J],2002(03).
2National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests; approved standard-seventh edition[S], NCCLS M100-S10(M7), January 2000
3Barry AL, Jones RN. Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination [J]. J Clin Microbiol 1988,26:13-17
4Williams JD. β-lactamase inhibition and in vitro activity of sulbactam and sulbactam-cefoperazone [J]. Clin Infect Dis,1997,24:494-497
5Fass RJ, Gregory WW, D'Amato RF, et al. In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermeuters [J]. Antimicrob Agents Chemother, 1990,34:2256-2259
6Deguchi K, Yokota N, Koguchi M, et al. Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against β-lactamase producing microorganisms. Results with the use of microdiffusion broth method[J]. Jpn J Antibiot, 1990,43:1214-1224
7Shinagawa N, Takeda S, Ochira S, et al. Efficacy and safety of sulbactam-cefoperazone for hepato-biliary infections[J]. Jpn J Antibiot, 1997,50:862-870
8Winston DJ, Bartoni K, Bruckner DA, et al. Randomized comparison of sulbactam-cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients[J]. Clin Infect Dis, 1998, 26:576-583
9Greenberg RN, Cayavec P, Danko LS, et al. Comparison of cefoperazone plus sulbactam with clindamycin plus gentamicin as treatment for intra-abdominal infections [J]. J Antimicrob Chemother, 1994,34:391-401
10Motojima S, Asakawa J, Ezure M, et al. Multicenter study of the effects of sulbactam-cefoperazone on bacterial infections in the fields of internal medicine focused mainly on respiratory infections in Tochigi Prefecture[J]. Jpn J Antibiot, 1993, 46:918-925
